!["I can’t make [treatment] decisions for you, but I can give you realistic expectations," said Herbert Lepor, MD, of NYU Langone Health.](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/11e93c561a9ff98f731b152d7f48e6f792831864-1000x1000.jpg?w=350&fit=crop&auto=format)
|Articles|December 14, 2010
Join 2 text
Advertisement
Oncology News International reader,
this community is yours. Come learn.
CancerNetwork.com offers everything you loved about Oncology News International, plus more.
You’ll get:
- Updates via email
- The ability to comment on articles on blogs \
- Access to Oncology, back issues of Oncology News International, advice from The Cancer Management Handbook
- News on trends, controversies, and new findings
- Single-click tools to share important articles and blogs with staff and colleagues
- Full access
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Accepts NDA for Daraxonrasib in Pretreated Metastatic Pancreatic Cancer
2
RASolute 302 and the Future of Pancreatic Cancer Treatment: Paul Oberstein, MD, on the KRAS Breakthrough
3
Mapping the Full CAR T-Cell Journey in DLBCL From Referral to Survivorship
4
Optimizing Surveillance Protocols After Focal Therapy for Prostate Cancer
5






















































